The Global High Potency API CDMOs Market is expected to witness a high and a single-digit growth by 2027. The principal factors fueling the market’s growth are growing demand for oncology medications, ...

AbbVie is investing $195 million in a new API facility in North Chicago, operational by 2027, to enhance US chemical synthesis capabilities. The investment is part of a $10 billion commitment to boost ...

Outsource API manufacturing to India for lower costs, GMP-compliant quality, scalable production, and faster time-to-market for pharma companies.

AbbVie is investing $380 million to build two new active pharmaceutical ingredient (API) manufacturing facilities at its ...

The global biotech API manufacturing services market, valued at US$ 38.9 Billion in 2022, is projected to grow at a CAGR of 7.1% from 2023 to 2031, surpassing US$ 73 Billion by 2031. biotech API ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

In the latest of a series of warning letters to India-based API manufacturers, FDA issued a warning letter to Aspen for deviations in CGMP in the production of APIs. FDA’s Center for Drug Evaluation ...

(MENAFN- IMARC Group) Setting up an API Manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw ...

Active Pharmaceutical Ingredients (APIs) are the biologically active components in pharmaceutical drugs that are responsible for the therapeutic effects. In simple terms, APIs are the key ingredient ...